CD23 during SIT

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 56, Issue 9, 2001, Pages 917-918

  Alesina, R ^a   De Amici, M ^a   Quaglini, S ^a   Puggioni, F ^a   Moratti, R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Atopy; Immunotherapy; sCD23

Indexed keywords

ALLERGEN; CD23 ANTIGEN; IMMUNOGLOBULIN E;

ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; DESENSITIZATION; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; REGRESSION ANALYSIS; RHINOCONJUNCTIVITIS; SERUM;

DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; MALE; RECEPTORS, IGE;

EID: 0034860808     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2001.00202.x     Document Type: Article

References (6)

1. Cells and cytokines in pollinosis
2. Decrease of serum levels of soluble CD23 during immunotherapy in patients with perennial allergic rhinitis
3. Immunotherapy decreases seasonal rise in serum-soluble CD23 in seasonal allergic rhinitis
4. Evaluation of soluble components of receptors with weak affinity for IgE (sCD23) in children with pollinosis given specific immunotherapy